Westjet Airlines Var (WJAVF) 17.7900 $WJAVF Media

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Westjet Airlines Var (WJAVF) 17.7900 $WJAVF

Media Advisory - Industrials companies to present at CIBC investor conference
CNW Group - Fri May 13, 10:38AM CDT
Executives from 10 industrials companies will outline their business plans and growth strategies at the CIBC (TSX: CM) Industrials Conference in Toronto on May 18.
CNI: 59.97 (+1.13), CM: 79.14 (+1.14), CM.TO: 102.36 (+0.15)

WestJet reports on voting results from 2016 annual general meeting of shareholders
PR Newswire - Tue May 03, 5:19PM CDT
WestJet Airlines Ltd. (TSX: WJA) (WestJet) announced today the voting results from its Annual General Meeting held Tuesday May 3, 2016 in Calgary, Alberta. The total number of shares represented by shareholders present in person and by proxy at the meeting was 63.7 million representing 52.1 per cent of WestJet's issued and outstanding Common Voting Shares and Variable Voting Shares.
WJA.TO: 23.07 (+0.11)

WestJet amends normal course issuer bid
PR Newswire - Tue Feb 02, 5:28AM CST
WestJet Airlines Ltd. (TSX:WJA) announced today that the Toronto Stock Exchange ("TSX" has approved an amendment to its normal course issuer bid (the "NCIB" . The purpose of the amendment is to increase the maximum number of common voting shares and variable voting shares (collectively "Shares" that may be purchased under the NCIB from 4,000,000 to 6,000,000. This represents approximately 4.75 per cent of the issued and outstanding Shares as of the date of the original notice. The increased purchase limit under the NCIB will be effective February 4, 2016.
WJA.TO: 23.07 (+0.11)

Karen Sheriff joins WestJet's Board of Directors
PR Newswire - Wed Jan 13, 5:23PM CST
WestJet Airlines Ltd. (TSX:WJA) today announced the appointment of Karen Sheriff, as an independent director, to its Board of Directors. The appointment is effective immediately and will bring the total number of Board members to thirteen.
WJA.TO: 23.07 (+0.11)

Global Low-Cost Airline Market Report - Analysis, Technologies & Forecasts - Companies Mentioned: Ryanair, Southwest Airlines & More
M2 - Wed Jan 13, 10:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/s4wx5m/the_global) has announced the addition of Canadean Ltd's new report "The Global Low-Cost Airline Market to 2019" to their offering. In terms of revenue the global airline industry has grown rapidly over the years. As per the International Air Transport Association (IATA) revenues increased from US$369 billion in 2004 to US $746 billion in 2014. Much of this growth could be attributed to the growth in the low-cost carriers (LCCs) which control almost 25% of the worldwide market. The report provides detailed information on global low-cost airlines industry analyzing market data and providing insights. Key Topics Covered: - Historic and forecast revenue of global low cost airlines market covering 40 countries - Detailed region-wise (Americas Asia-Pacific Europe Middle East and Africa) of low cost airlines' key performance indicators such as the number of seats available and seats sold load factor, the average revenue per passenger, total revenues, revenue generating passenger kilometers and passenger kilometers available for the historic (2010-2014) and forecast (2015-2019) periods - Brief analysis of global low cost airlines market and the present scenario - Detailed analysis of the markets trends in key low cost airlines' markets Benefits of this Report: - Make strategic business decisions using historic and forecast market data related to global low-cost airlines industry - Understand the demand-side dynamics within the industry to identify key market trends and growth opportunities Companies Mentioned: - Southwest Airlines Co. - JetBlue Airways Corporation - Ryanair Holdings Plc - easyJet Plc - Gol Linhas A?reas Inteligentes SA - SpiceJet Ltd - Norwegian Air Shuttle AS - Jetstar Airways Pty Ltd - WestJet Airlines Ltd - AirAsia Bhd - Dubai Avi Report Structure: 1 Global Low-Cost Airline Market - Key Trends 2 Global Low-Cost Airline Deals 3 Global Low-Cost Airline KPIs - the Americas 4 Global Low-Cost Airline KPIs - Asia-Pacific 5 Global Low-Cost Airline KPIs - Europe 6 Global Low-Cost Airline KPIs - the Middle East and Africa 7 Global Low-Cost Airline Profiles 8 Appendix For more information visit http://www.researchandmarkets.com/research/s4wx5m/the_global
RYAAY: 87.17 (-0.24), JBLU: 17.73 (-0.24), LUV: 41.69 (-0.48)

Christopher Burley joins WestJet's Board of Directors
PR Newswire - Mon Sep 21, 11:17AM CDT
WestJet Airlines Ltd. (TSX:WJA) today announced the appointment of Christopher Burley, as an independent director, to its Board of Directors. The appointment is effective immediately and will bring the total number of Board members to twelve.
WJA.TO: 23.07 (+0.11)

WestJet Encore Places Firm Orders for Six Bombardier Q400 Airliners
Marketwired - Mon Jun 15, 6:58AM CDT
International Paris Air Show

WestJet announces normal course issuer bid
PR Newswire - Fri May 08, 4:15PM CDT
WestJet Airlines Ltd. (TSX:WJA) announced today that the Toronto Stock Exchange (TSX) has accepted its notice of intention to make a normal course issuer bid to purchase outstanding common voting and variable voting shares (the Shares) on the open market in accordance with the rules of the TSX.
WJA.TO: 23.07 (+0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading